<DOC>
	<DOCNO>NCT01416064</DOCNO>
	<brief_summary>Open-label , extension study subject complete 810P202 examine long term safety tolerability repeat dose SPN-810M adjunctive therapy child Impulsive Aggression Comorbid Attention-Deficit/Hyperactivity Disorder ( ADHD ) .</brief_summary>
	<brief_title>Open-Label , Extension Study 810P202</brief_title>
	<detailed_description />
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Aggression</mesh_term>
	<mesh_term>Molindone</mesh_term>
	<criteria>1 . Successful completion 810P202 study . 2 . Continues medically healthy clinically normal laboratory profile , vital sign , electrocardiogram ( ECGs ) . 3 . Weight least 20kg . 4 . Able willing swallow tablet whole chew , cut crush . 5 . Written inform consent/assent obtain subject 's parent legallyauthorized representative ( LAR ) , write informed assent obtain subject require . 1 . Body Mass Index ( BMI ) 97th percentile . 2 . Clinically significant change health status , opinion Investigator , would prevent subject participate study successfully complete study . 3 . Pregnancy refusal practice contraception study ( female subject childbearing potential ) . 4 . Any reason , opinion Investigator , would prevent subject participate study comply study procedure .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>